AstraZeneca@AstraZeneca
#News Today we announced we will invest US$4.5 billion in a new manufacturing facility in Virginia— which includes a proposed $500m increase to enhance manufacturing capabilities to bring a broader range of medicines, including cancer, to patients in the US and worldwide.
#AZN

Opens with a number





